Intrinsic Value of S&P & Nasdaq Contact Us

Gritstone bio, Inc. GRTS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.67
+14403.1%

Stock Statistics — GRTS

Gritstone bio, Inc. (GRTS) has a market capitalization of $3.8M and trades at $0.03. The 52-week range is 0.03-3.17.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.20, annual revenue of $1.33M.

The stock has a beta of 0.50, operates in the Healthcare sector.

Trading Data
Current Price$0.03
52-Week Range0.03-3.17
Volume55.25M
Avg Volume (30D)17.01M
Market Cap$3.8M
Beta (1Y)0.50
Company
IPO Date2018-09-28
Employees231
CEOAndrew R. Allen BCh, BM, MA, MRCP,
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS39868T1051
CUSIP39868T105
Income (Latest Year)
Revenue$1.33M
Gross Profit$-6.26M
EBITDA$-126.86M
Operating Income$-154.63M
Net Income$-138.49M
EPS$-1.20
EPS Diluted$-1.20
Shares Outstanding$115.53M
Balance Sheet (Latest Year)
Total Assets$177.77M
Current Assets$87.44M
Cash & ST Investments$81.57M
Total Liabilities$125.92M
Total Debt$104.78M
Net Debt$39.49M
Total Equity$51.85M
Debt / Equity2.02
Valuation Ratios
P/E Ratio-0
P/S Ratio2.86
P/B Ratio0.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message